Human papillomaviruses and cervical cancer

Area of Science:

• Oncology
• Virology
• Immunology

Background:

• Cervical carcinoma is a significant global health concern for women.
• High-risk human papillomaviruses (HPVs) are the primary cause of cervical cancer.
• Understanding the HPV life cycle and its cellular impact is crucial for developing interventions.

Purpose of the Study:

• To review laboratory findings over the past two decades concerning the HPV life cycle.
• To identify the functions of viral proteins and the cellular consequences of HPV infection.
• To outline the development of strategies for preventing and treating HPV-induced cervical cancer.

Main Methods:

• Comprehensive literature review of laboratory studies on HPV over 20 years.
• Analysis of research elucidating HPV's life cycle, protein functions, and host cell interactions.
• Synthesis of information leading to the development of preventive and therapeutic strategies.

Main Results:

• Detailed understanding of the human papillomavirus (HPV) life cycle.
• Identification of key viral protein functions and their roles in pathogenesis.
• Clarification of HPV's impact on host cell biology.
• Development of prophylactic vaccines (virus-like particles), therapeutic vaccines, and antiviral treatments.

Conclusions:

• Knowledge of HPV biology has facilitated the creation of diverse prevention and treatment modalities.
• These strategies hold significant potential to reduce the global incidence of cervical carcinoma.
• The approaches developed for HPV serve as a model for combating other virus-induced cancers.